Use of AI-based tools for healthcare purposes: a survey study from consumers’ perspectives

Abstract

Background Several studies highlight the effects of artificial intelligence (AI) systems on healthcare delivery. AI-based tools may improve prognosis, diagnostics, and care planning. It is believed that AI will be an integral part of healthcare services in the near future and will be incorporated into several aspects of clinical care. Thus, many technology companies and governmental projects have invested in producing AI-based clinical tools and medical applications. Patients can be one of the most important beneficiaries and users of AI-based applications whose perceptions may affect the widespread use of AI-based tools. Patients should be ensured that they will not be harmed by AI-based devices, and instead, they will be benefited by using AI technology for healthcare purposes. Although AI can enhance healthcare outcomes, possible dimensions of concerns and risks should be addressed before its integration with routine clinical care. Methods We develop a model mainly based on value perceptions due to the specificity of the healthcare field. This study aims at examining the perceived benefits and risks of AI medical devices with clinical decision support (CDS) features from consumers’ perspectives. We use an online survey to collect data from 307 individuals in the United States. Results The proposed model identifies the sources of motivation and pressure for patients in the development of AI-based devices. The results show that technological, ethical (trust factors), and regulatory concerns significantly contribute to the perceived risks of using AI applications in healthcare. Of the three categories, technological concerns (i.e., performance and communication feature) are found to be the most significant predictors of risk beliefs. Conclusions This study sheds more light on factors affecting perceived risks and proposes some recommendations on how to practically reduce these concerns. The findings of this study provide implications for research and practice in the area of AI-based CDS. Regulatory agencies, in cooperation with healthcare institutions, should establish normative standard and evaluation guidelines for the implementation and use of AI in healthcare. Regular audits and ongoing monitoring and reporting systems can be used to continuously evaluate the safety, quality, transparency, and ethical factors of AI-based services.

Predicting outcomes in older ED patients with influenza in real time using a big data-driven and machine learning approach to the hospital information system

“…In recent years, the rapid progression of cloud and IoT (internet of things) by healthcare monitor and wearable sensor networks also greatly support the development of real-time AI prediction [ 8 ]. Therefore, the AI-based tools, which are designed to improve diagnosis, care planning, and outcome will be incorporated into healthcare services in the near future [ 9 ]. Many regulations about AI use in healthcare need to be developed, including establishment of normative standard, evaluation guidelines, and monitoring and reporting systems [ 9 ].…”

“…Therefore, the AI-based tools, which are designed to improve diagnosis, care planning, and outcome will be incorporated into healthcare services in the near future [9]. Many regulations about AI use in healthcare need to be developed, including establishment of normative standard, evaluation guidelines, and monitoring and reporting systems [9]. The adopted feature variables in this study, including comorbidities and abnormal vital signs and laboratory data, are the risk factors for poor outcomes.…”

Precision strength training: Data-driven artificial intelligence approach to strength and conditioning

“…We disruptive AI-driven companies taking similar marketing-heavy paths [218,283,545,730]. [673,707,758,890], but with collaborative interest from sports scientists, the models developed e.g.…”

A Proposed Framework on Integrating Health Equity and Racial Justice into the Artificial Intelligence Development Lifecycle

“…The result is an exacerbation of structural inequities and adverse outcomes when disadvantaged populations are not included in trial data. 29,44 Another unfortunate consequence in product development is the mismatch of the intended use and subsequent actual use. This could happen when there is lack of accountability and moral agency for the entire process from design and development to implementation.…”